4USE

Human STK10 (LOK) with SB-633825


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.65 Å
  • R-Value Free: 0.251 
  • R-Value Work: 0.225 
  • R-Value Observed: 0.226 

wwPDB Validation 3D Report Full Report


This is version 1.3 of the entry. See complete history


Literature

Comprehensive Characterization of the Published Kinase Inhibitor Set.

Elkins, J.M.Fedele, V.Szklarz, M.Abdul Azeez, K.R.Salah, E.Mikolajczyk, J.Romanov, S.Sepetov, N.Huang, X.P.Roth, B.L.Al Haj Zen, A.Fourches, D.Muratov, E.Tropsha, A.Morris, J.Teicher, B.A.Kunkel, M.Polley, E.Lackey, K.E.Atkinson, F.L.Overington, J.P.Bamborough, P.Moller, S.Price, D.J.Willson, T.M.Drewry, D.H.Knapp, S.Zuercher, W.J.

(2016) Nat Biotechnol 34: 95

  • DOI: 10.1038/nbt.3374
  • Structures With Same Primary Citation

  • PubMed Abstract: 
  • Despite the success of protein kinase inhibitors as approved therapeutics, drug discovery has focused on a small subset of kinase targets. Here we provide a thorough characterization of the Published Kinase Inhibitor Set (PKIS), a set of 367 small-mo ...

    Despite the success of protein kinase inhibitors as approved therapeutics, drug discovery has focused on a small subset of kinase targets. Here we provide a thorough characterization of the Published Kinase Inhibitor Set (PKIS), a set of 367 small-molecule ATP-competitive kinase inhibitors that was recently made freely available with the aim of expanding research in this field and as an experiment in open-source target validation. We screen the set in activity assays with 224 recombinant kinases and 24 G protein-coupled receptors and in cellular assays of cancer cell proliferation and angiogenesis. We identify chemical starting points for designing new chemical probes of orphan kinases and illustrate the utility of these leads by developing a selective inhibitor for the previously untargeted kinases LOK and SLK. Our cellular screens reveal compounds that modulate cancer cell growth and angiogenesis in vitro. These reagents and associated data illustrate an efficient way forward to increasing understanding of the historically untargeted kinome.


    Organizational Affiliation

    Chemical Sciences, GlaxoSmithKline, Research Triangle Park, North Carolina, USA.



Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
SERINE/THREONINE-PROTEIN KINASE 10
A, B
302Homo sapiensMutation(s): 0 
Gene Names: STK10LOK
EC: 2.7.11.1
Find proteins for O94804 (Homo sapiens)
Go to UniProtKB:  O94804
NIH Common Fund Data Resources
PHAROS  O94804
Protein Feature View
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
R09
Query on R09

Download CCD File 
A, B
4-{5-(6-methoxynaphthalen-2-yl)-1-methyl-2-[2-methyl-4-(methylsulfonyl)phenyl]-1H-imidazol-4-yl}pyridine
C28 H25 N3 O3 S
ZDSNJSQTPLXCSG-UHFFFAOYSA-N
 Ligand Interaction
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.65 Å
  • R-Value Free: 0.251 
  • R-Value Work: 0.225 
  • R-Value Observed: 0.226 
  • Space Group: P 1 21 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 62.04α = 90
b = 50.25β = 101.16
c = 133.71γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
MOSFLMdata reduction
SCALAdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

Revision History 

  • Version 1.0: 2015-07-22
    Type: Initial release
  • Version 1.1: 2015-11-04
    Changes: Database references
  • Version 1.2: 2016-01-20
    Changes: Database references
  • Version 1.3: 2018-01-24
    Changes: Structure summary